Clinical Trials › NCT05054140
Active, Not RecruitingPhase 2
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
Sponsored by Immunic AG
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 450
Target enrollment
6
U.S. states
Sep 2021
Start date
Jan 2025
Expected completion
Interventions / Treatments
IMU-838Placebo matching IMU-838
Conditions studied
Multiple Sclerosis
Participating MS centers on MS Buddy (5)
Collier Neurologic Specialists
Naples, FL
Naples, FL
Johns Hopkins Multiple Sclerosis Center
Baltimore, MD
Baltimore, MD
Andrew C. Carlos MS Institute at Shepherd
Atlanta, GA
Atlanta, GA
MS centers in Florida
Compare treatment centers near a trial site — patient experience, providers, and care ratings.
View Florida centersMore Phase 2 trials
Browse all Phase 2 MS trialsCheck out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
